Zobrazeno 1 - 10
of 392
pro vyhledávání: '"MONOCLONAL-ANTIBODY ALK1"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
S, Pittaluga, I, Wlodarska, K, Pulford, E, Campo, S W, Morris, H, Van den Berghe, C, De Wolf-Peeters
Publikováno v:
The American journal of pathology. 151(2)
Anaplastic large cell lymphoma (ALCL) is a heterogeneous group of diseases by morphology, phenotype, genotype, and clinical presentation. Using a new monoclonal antibody (ALK1) that recognizes the native anaplastic lymphoma kinase (ALK) protein as we
Publikováno v:
Blood. 89(4)
The t(2;5)(p23;q35) translocation, associated with anaplastic large-cell lymphoma (ALCL), results in the production of the nucleolar protein nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) protein. This report describes an immunocytochemical study
Autor:
Sung, Yeoun Eun1 (AUTHOR) yesung@catholic.ac.kr, Kim, Meejeong1 (AUTHOR)
Publikováno v:
Thoracic Cancer. Oct2024, Vol. 15 Issue 30, p2175-2184. 10p.
Autor:
J. C. Kluin-Nelemans, Antonino Carbone, I. Teodorovic, C De Wolf-Peeters, Brigitte Maes, Ruth Achten, A. Anastasopoulou
Publikováno v:
Annals of Oncology, 12(6), 853-858. Oxford University Press
Background: The EORTC clinical trial 20901, activated in 1990, was designed to treat non-Hodgkin's lymphomas (NHL) of intermediate/high-grade malignancy according to the Working Formulation. Established in 1994, the R.E.A.L. Classification on NHL has
Publikováno v:
Annals of Oncology. 12(6):853-858
Background: The EORTC clinical trial 20901, activated in 1990, was designed to treat non-Hodgkin's lymphomas (NHL) of intermediate/high-grade malignancy according to the Working Formulation. Established in 1994, the R.E.A.L. Classification on NHL has
Publikováno v:
Laboratory Investigation. 81(3):419-426
The majority of anaplastic large cell lymphomas (ALCL) are associated with chromosomal abnormalities affecting the anaplastic lymphoma kinase (ALK) gene which result in the expression of hybrid AFK fusion proteins in the tumor cells. In most of these
Autor:
Frederic Tort, Magda Pinyol, Christian Touriol, Giovanna Roncador, Karen Pulford, Hanneke C. Kluin-Nelemans, Georges Delsol, Philip M. Kluin, Lluis Hernández, Elias Campo, Iracema Nayach, David Y. Mason
Publikováno v:
Laboratory Investigation, 81(3), 419-426. SPRINGERNATURE
Scopus-Elsevier
Scopus-Elsevier
The majority of anaplastic large cell lymphomas (ALCL) are associated with chromosomal abnormalities affecting the anaplastic lymphoma kinase (ALK) gene which result in the expression of hybrid ALK fusion proteins in the tumor cells. In most of these
Autor:
Mousa, Danai-Priskila V.1 (AUTHOR) danaemusa@gmail.com, Mavrovounis, Georgios2,3 (AUTHOR) gmavrovounis@gmail.com, Argyropoulos, Dionysios4 (AUTHOR) dionargi66@gmail.com, Stranjalis, George3 (AUTHOR), Kalamatianos, Theodosis3 (AUTHOR) tkalamatian@med.uoa.gr
Publikováno v:
Cancers. Feb2024, Vol. 16 Issue 3, p650. 17p.